HomeCompareEDTXF vs BTI

EDTXF vs BTI: Dividend Comparison 2026

EDTXF yields 203.25% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EDTXF wins by $131.05M in total portfolio value
10 years
EDTXF
EDTXF
● Live price
203.25%
Share price
$0.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$131.09M
Annual income
$66,614,308.55
Full EDTXF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — EDTXF vs BTI

📍 EDTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEDTXFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EDTXF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EDTXF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EDTXF
Annual income on $10K today (after 15% tax)
$17,276.42/yr
After 10yr DRIP, annual income (after tax)
$56,622,162.27/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, EDTXF beats the other by $56,619,793.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EDTXF + BTI for your $10,000?

EDTXF: 50%BTI: 50%
100% BTI50/50100% EDTXF
Portfolio after 10yr
$65.56M
Annual income
$33,308,547.59/yr
Blended yield
50.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

EDTXF
No analyst data
Altman Z
-75.3
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EDTXF buys
0
BTI buys
0
No recent congressional trades found for EDTXF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEDTXFBTI
Forward yield203.25%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$131.09M$37.7K
Annual income after 10y$66,614,308.55$2,786.64
Total dividends collected$123.65M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EDTXF vs BTI ($10,000, DRIP)

YearEDTXF PortfolioEDTXF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$31,025$20,325.20$11,299$598.92+$19.7KEDTXF
2$92,131$58,933.98$12,794$703.91+$79.3KEDTXF
3$262,139$163,558.41$14,518$829.07+$247.6KEDTXF
4$715,413$434,925.03$16,513$978.64+$698.9KEDTXF
5$1,874,812$1,109,319.79$18,827$1,157.84+$1.86MEDTXF
6$4,722,949$2,716,900.45$21,518$1,373.12+$4.70MEDTXF
7$11,450,101$6,396,545.74$24,657$1,632.46+$11.43MEDTXF
8$26,744,592$14,492,983.16$28,329$1,945.74+$26.72MEDTXF
9$60,254,103$31,637,389.98$32,637$2,325.33+$60.22MEDTXF
10$131,086,199$66,614,308.55$37,708$2,786.64+$131.05MEDTXF

EDTXF vs BTI: Complete Analysis 2026

EDTXFStock

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Full EDTXF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this EDTXF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EDTXF vs SCHDEDTXF vs JEPIEDTXF vs OEDTXF vs KOEDTXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.